Interrelationship of 3-deazaguanine-induced growth inhibitory actions in L1210 cells

UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.

Oncogene·2016

PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.

Oncogene·2008

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells.

Cell death and differentiation·2006

Update on caffeine consumption, disposition and action.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2002

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

Cancer research·2001

Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.

Cancer research·2001

Genistein targets Wnt5a to alleviate temporomandibular joint osteoarthritis by suppressing JNK/JUN-dependent MMP9 activation.

Biochemical pharmacology·2026

Context-dependent protective and pathogenic functions of YTHDF1 in MASLD and hepatocellular carcinoma: Mechanisms and design of therapeutics.

Biochemical pharmacology·2026

Metabolism-mediated herb-drug interaction between milk thistle and resmetirom in MCD diet-induced metabolic dysfunction-associated steatohepatitis rat model.

Biochemical pharmacology·2026

Citicoline in cardiovascular protection: mechanistic roles of choline and acetylcholine.

Biochemical pharmacology·2026

Monocarboxylate transporters 1 and 4 in tumor lactate exchange: Molecular mechanisms, pharmacological inhibition, and therapeutic translation.

Biochemical pharmacology·2026

Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma.

Biochemical pharmacology·2026

Design and synthesis of novel benzothiazole-pyrazole derivatives: cytotoxicity against panc-1 cancer cells and EGFR, antioxidant activity, molecular docking, MD simulations, ADMET, and DFT analysis.

In silico pharmacology·2026

Integrated computational and experimental identification of Aurora A kinase inhibitors for breast cancer therapy.

SAR and QSAR in environmental research·2026

Tuning the Triazolotriazine Scaffold Toward Selective A3 Adenosine Receptor Antagonists: From Molecular Recognition to Neuroprotection.

ChemMedChem·2026

Sesquiterpenes from the rhizomes of Acorus calamus var. angustatus Besser and their neuroprotective properties.

Natural product research·2026

Pharmacophore modelling-based screening of natural allosteric EGFR inhibitors using molecular docking, DFT, and molecular dynamics simulations.

Journal of molecular graphics & modelling·2026

Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors.

Future medicinal chemistry·2026

Related Experiment Videos

Interrelationship of 3-deazaguanine-induced growth inhibitory actions in L1210 cells

Related Concept Videos

UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.

PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells.

Update on caffeine consumption, disposition and action.

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.

Genistein targets Wnt5a to alleviate temporomandibular joint osteoarthritis by suppressing JNK/JUN-dependent MMP9 activation.

Context-dependent protective and pathogenic functions of YTHDF1 in MASLD and hepatocellular carcinoma: Mechanisms and design of therapeutics.

Metabolism-mediated herb-drug interaction between milk thistle and resmetirom in MCD diet-induced metabolic dysfunction-associated steatohepatitis rat model.

Citicoline in cardiovascular protection: mechanistic roles of choline and acetylcholine.

Monocarboxylate transporters 1 and 4 in tumor lactate exchange: Molecular mechanisms, pharmacological inhibition, and therapeutic translation.

Overcoming drug delivery barriers to Unlock the therapeutic potential of conventional chemotherapy in glioblastoma.

Design and synthesis of novel benzothiazole-pyrazole derivatives: cytotoxicity against panc-1 cancer cells and EGFR, antioxidant activity, molecular docking, MD simulations, ADMET, and DFT analysis.

Integrated computational and experimental identification of Aurora A kinase inhibitors for breast cancer therapy.

Tuning the Triazolotriazine Scaffold Toward Selective A3 Adenosine Receptor Antagonists: From Molecular Recognition to Neuroprotection.

Sesquiterpenes from the rhizomes of Acorus calamus var. angustatus Besser and their neuroprotective properties.

Pharmacophore modelling-based screening of natural allosteric EGFR inhibitors using molecular docking, DFT, and molecular dynamics simulations.

Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors.

Related Experiment Videos

Interrelationship of 3-deazaguanine-induced growth inhibitory actions in L1210 cells

Related Concept Videos

Related Articles